On the COVID-19 Vaccine

On the COVID-19 Vaccine

Grace Huang, Journalist, Editor

In mid-March of 2020, the World Health Organization confirmed the COVID-19 outbreak as a global pandemic. Eight months later, we haven’t seen any visible signs of cure advancement, or any miraculously true rumors that schools or other smaller or “unnecessary” facilities would reopen. However, recent news feeds from various websites headline articles about a potential COVID-19 vaccine. Perhaps there’s more hope for an early end to this situation than we’d anticipated after all.

According to the National Institutes of Health, a vaccine named mRNA-1273 is being co-developed alongside biotech company Moderna, Inc. The vaccine itself was made to target a specific “spike” protein found in COVID-19, which the pathogen uses to bind and enter human cells, thereby infecting a person. 

So far, there have been three phases of experimentation evaluated before the official widespread release of the vaccine, conducted in order to ensure the effectiveness and safety of an injection. These experiments consist of multiple injections of the in-development vaccine into a certain number of participants. The data collected is used to perfect the final result, which will hopefully soon be released officially to the public.

Most participants of the experiments experienced little to no side effects after the injection, and various videos and articles prove that the vaccine research and development is well underway. It may only be a few more months before it is perfected and distributed, and until then, we can hold out hope that our situation will gradually become more organized and improve.

 

Links and Citations: